Product
TNB-738
1 clinical trial
1 indication
Indication
Healthy VolunteerClinical trial
A Phase 1, Double-blind, Single- and Multiple-ascending Dose Escalation Study of TNB-738, a Biparatopic Antibody Targeting CD38 in Healthy VolunteersStatus: Completed, Estimated PCD: 2023-05-04